Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Closed 12-11 16:00:00 EST

838.41

+8.74

+1.05%

High846.10	Low829.62	Vol411.82M
Open829.67	D1 Closing829.67	Amplitude1.99%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O15.17B	T/O Rate--	Tradable Shares0.00
P/B4.990116	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":838.4102,"timestamp":1765486799999,"preClose":829.669,"halted":0,"volume":411818403,"delay":0,"changeRate":0.010536,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":8.741211,"latestTime":"12-11 16:00:00 EST","open":829.669,"high":846.09924,"low":829.6186,"amount":15174269807.919224,"amplitude":0.019864,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765530000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.990116,"peRate":24.17914,"turnoverRate":0.009025,"increases":94,"decrements":90,"flats":6,"marketCap":3325265631586,"floatMarketCap":3173107034757.0625},"requestUrl":"/m/hq/s/BK4007/tweets","defaultTab":"tweets","newsList":[{"id":"1119287037","title":"Average Weight Loss of 28.7% After One-Year Treatment! Eli Lilly's Next-Gen Obesity Drug Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=1119287037","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119287037?lang=en_us&edition=fundamental","pubTime":"2025-12-12 08:32","pubTimestamp":1765499532,"startTime":"0","endTime":"0","summary":"Eli Lilly has unveiled groundbreaking Phase 3 clinical trial results for its next-generation obesity drug, retatrutide. Patients in the highest-dose group achieved an average weight loss of 28.7%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU2471134523.USD","LU0689472784.USD","LU2471134879.HKD","LU0385154629.USD","LU2361045086.USD","LU0354030511.USD","LU0266013472.USD","IE00B2B36J28.USD","LU0114720955.EUR","IE0002141913.USD","LU0320765992.SGD","LU2552382215.SGD","LU0882574055.USD","LU2360106947.USD","LU1868836591.USD","LU2237443622.USD","LU0672654240.SGD","IE00BN29S564.USD","SGXZ99366536.SGD","LU0094547139.USD","IE00BJJMRY28.SGD","LU2491050154.USD","LU2602419157.SGD","LU2468319806.SGD","LU2471134796.USD","LU0353189680.USD","SG9999001176.SGD","SG9999018857.SGD","LU0466842654.USD","IE0004445015.USD","LU1988902786.USD","LU0640476718.USD","LU0203202063.USD","LU0234572021.USD","LU2265009873.SGD","LU0323591593.USD","SGXZ51526630.SGD","LU1232071149.USD","LU0109394709.USD","LU2168564065.EUR","LU0289739699.SGD","LU0823434740.USD","LU2471134952.CNY","LU0882574139.USD","IE00BJJMRX11.SGD","IE00BWXC8680.SGD","LU1551013425.SGD","LU0354030438.USD","IE0005OL40V9.USD","LU0109391861.USD","LU2108987350.USD","LU0316494557.USD","LU2237443549.SGD","BK4581","BK4007","LU0823434583.USD","BK4534","IE00B1XK9C88.USD","IE0009355771.USD","LU1064131342.USD","LU2023250504.SGD","LU2087625088.SGD","LU2236285917.USD","BK4516","SGXZ81514606.USD","LU0096364046.USD","BK4533","LU1267930730.SGD","LU2357305700.SGD","LU0079474960.USD","LU1127390331.HKD","LU0320765059.SGD","IE00B4JS1V06.HKD","LU2461242641.AUD","LU1868836757.USD","LU1720051108.HKD","LU2456880835.USD","LU0456855351.SGD","IE00BKDWB100.SGD","IE0004445239.USD","SG9999014906.USD","IE00BFTCPJ56.SGD","LU1974910355.USD","SG9999014914.USD","LU0097036916.USD","SG9999015978.USD","LU2168564495.EUR","LU2746668974.SGD","LU1023059063.AUD","LU0058720904.USD","LU0471298694.HKD","LU0471298777.SGD","SG9999014880.SGD","SGXZ31699556.SGD","LU2168564222.USD","LU2552382132.HKD","BK4588","LU2237443978.SGD","LU1093756168.USD","LU2211815571.USD","LU1551013342.USD","LU2168564149.EUR","LU1989771016.USD","LU0106261372.USD","LU1323610961.USD","IE00BFSS7M15.SGD","LU0006306889.USD","LU0122379950.USD","LU1868837136.USD","LU1548497426.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU2462157665.USD","LU2491050071.SGD","LU1712237335.SGD","LU2168563687.JPY","LU2746668461.USD","GB00BDT5M118.USD","LU0820561818.USD","LU2324357040.USD","LU0432979614.USD","IE00BFSS8Q28.SGD","LU1069344957.HKD","SG9999015986.USD","IE00B7KXQ091.USD","LU0061475181.USD","LU0708995401.HKD","LU0238689110.USD","LU0203201768.USD","LU2089984988.USD","LU1983299246.USD","LU1917777945.USD","LU1814569148.SGD","LU0823416689.USD","LU0943347566.SGD","LU2361044949.HKD","LU2063271972.USD","LU2417539215.USD","IE00B1BXHZ80.USD","LU2237443382.USD","IE00BK4W5L77.USD","BK4599","IE00BK4W5M84.HKD","LU1057294990.SGD","SG9999017495.SGD","LU0786609619.USD","LU2491049909.HKD","LU2361044865.SGD","LU2112291526.USD","IE00BKPKM429.USD","LU2237443465.HKD","LU1291159041.SGD","LU2750360997.AUD","LU2237438978.USD","LU0353189763.USD","LU1280957306.USD","LU1804176565.USD","BK4585","SGXZ57979304.SGD","LU0889565916.HKD","SG9999018865.SGD","SG9999001176.USD","LU0417517546.SGD","LLY","LU0256863811.USD","IE00B775H168.HKD","LU1868836914.USD","LU1093756325.SGD","SG9999014898.SGD","IE00BJT1NW94.SGD","LU2264538146.SGD","LU0256863902.USD","LU1366192091.USD","LU1623119135.USD","LU0198837287.USD","LU1035775433.USD","IE00B4R5TH58.HKD","LU2552382058.USD","LU0820561909.HKD","SG9999015945.SGD","LU2750360641.GBP","LU1868837300.USD","LU2106854487.HKD","LU2237443895.HKD","LU1720051017.SGD","SG9999013999.USD","IE00BJLML261.HKD"],"gpt_icon":1},{"id":"2590479375","title":"Innoviva Specialty Therapeutics Publishes Positive Phase 3 Zoliflodacin Data in The Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2590479375","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590479375?lang=en_us&edition=fundamental","pubTime":"2025-12-12 07:35","pubTimestamp":1765496112,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innoviva Inc. published the original content used to generate this news brief via Business Wire  on December 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL2zbPCd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","SG9999015952.SGD","BK4588","LU1430594728.SGD","LU1718418525.SGD","LU0689472784.USD","IE00B3PB1722.GBP","IE00BN8TJ469.HKD","IE00BGHQF631.EUR","LU0795875086.SGD","LU1585245621.USD","LU0310800379.SGD","IE00BSNM7G36.USD","LU0545039389.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0820561818.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU0949170772.SGD","IE00B42XCP33.USD","LU1934455863.HKD","ABBV","BK4550","LU0943347566.SGD","LU0234570918.USD","BK4585","LU1934455277.USD","BK4559","LU0098860793.USD","LU2237443465.HKD","LU1732799900.SGD","LU1244550494.USD","LU1291159041.SGD","LU2089984988.USD","IE0004445239.USD","LU1983299246.USD","LU1003077747.HKD","LU2112291526.USD","IE0002141913.USD","LU0738911758.USD","INVA","LU1244550577.SGD","LU1267930573.SGD","LU0965509010.AUD","SG9999015978.USD","SG9999003800.SGD","LU1496350171.SGD","BK4007","LU0058720904.USD"],"gpt_icon":0},{"id":"2590939547","title":"Innoviva Specialty Therapeutics Announces Publication in the Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea","url":"https://stock-news.laohu8.com/highlight/detail?id=2590939547","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590939547?lang=en_us&edition=fundamental","pubTime":"2025-12-12 07:35","pubTimestamp":1765496100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA5SLHFX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INVA","BK4007"],"gpt_icon":0},{"id":"2590542374","title":"Foundation Fighting Blindness Retinal Degeneration Fund Sells Common Shares of Opus Genetics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2590542374","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590542374?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:36","pubTimestamp":1765492589,"startTime":"0","endTime":"0","summary":"Foundation Fighting Blindness Retinal Degeneration Fund reported a disposal of common shares of Opus Genetics Inc. , according to a recent SEC Form 4 filing. The form was filed by more than one reporting person, including Foundation Fighting Blindness Retinal Degeneration Fund and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL7htR86:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Foundation Fighting Blindness Retinal Degeneration Fund Sells Common Shares of Opus Genetics Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IRD","BK4139"],"gpt_icon":0},{"id":"2590440005","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2590440005","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590440005?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:26","pubTimestamp":1765491960,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slipped 1.84% to $2.13 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 1.34% to 48,704.01 and the NASDAQ Composite Index  falling 0.25% to 23,593.86.This was the stock's second consecutive day of losses.Inovio Pharmaceuticals Inc. closed 47.79% short of its 52-week high of $4.08, which the company reached on December 12th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  rose 1.68% to $210.01, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  rose 0.08% to $25.80.Trading volume  remained 275,281 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 11, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is publis","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134952.CNY","LU0985320562.USD","LU2430703178.SGD","SG9999001176.SGD","LU1430594728.SGD","LU1935042991.SGD","LU2505996509.AUD","LU2602419157.SGD","LU1061106388.HKD","LU2471134523.USD","SG9999011175.SGD","LU2129689431.USD","IE0002141913.USD","IE00BLSP4452.SGD","LU0114720955.EUR","LU1732799900.SGD","LU1162221912.USD","LU1059921491.USD","LU1496350502.SGD","LU2112291526.USD","INO","LU0058720904.USD","LU0456855351.SGD","BK4504","BK4007","BK4532","LU0466842654.USD","IE0009355771.USD","IE00BKVL7J92.USD","LU0170899867.USD","IE0034235303.USD","IE00B19Z3581.USD","LU1929549753.HKD","LU0098860793.USD","LU0912757837.SGD","IE00BSNM7G36.USD","IE00B3PB1722.GBP","LU1674673691.USD","LU0345769631.USD","IE00B42XCP33.USD","LU0203347892.USD","IE00BJT1NW94.SGD","BK4588","IE00BN8TJ469.HKD","BK4559","LU0432979614.USD","LU1261432733.SGD","LU0234570918.USD","IE00B3T34201.USD","LU2750360997.AUD","IE00BVYPNW00.USD","SG9999001176.USD","SG9999002224.SGD","LU1244550221.USD","IE00BGHQF631.EUR","LU0868494617.USD","BK4550","BK4581","LU0306807586.USD","SGXZ57979304.SGD","IE0002270589.USD","LU0070217475.USD","LU0321505439.SGD","LU0795875169.SGD","LU1718418525.SGD","BK4568","LU0882574055.USD","LU0345770993.USD","IE00BBT3K403.USD","LU2129689605.HKD","SG9999001440.SGD","LU2089984988.USD","LU1894683348.USD","LU1066053197.SGD","LU0320765646.SGD","IE00BDGV0183.EUR","BK4599","SG9999002232.USD","LU1066051811.HKD","LU2471134879.HKD","IE00BLSP4239.USD","LU2471134796.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4585","LU2750360641.GBP","LU1244550577.SGD","SG9999013999.USD","LU1032466523.USD","LU0234572021.USD","LU2129689514.USD","LU1074936037.SGD","IE00BVYPNV92.GBP","LU1778281490.HKD","LU2468319806.SGD","LU1221951129.SGD","LU1674673428.USD","LU2133065610.SGD","SG9999003800.SGD","LU0985481810.HKD","IE00BFXG1179.USD","LU2347655156.SGD","IE00BZ1G4Q59.USD","LU0640476718.USD","IE00B7SZLL34.SGD","BK4533","IE00B2B36J28.USD","LU1894683264.USD","LU0225771236.USD","LU0122379950.USD","LU1196500208.SGD","IE00BFTCPJ56.SGD","LU0345770308.USD","LU0889566641.SGD","LU1585245621.USD","BK4592","LU0321505868.SGD","LU1066051498.USD","LU1732800096.USD","BK4139","LU0345769128.USD","BK4534","IE00B19Z3B42.SGD","LU1023059063.AUD","IE00B1BXHZ80.USD","LU0225284248.USD","LU1914381329.SGD","LU1221951046.USD","LU0289739699.SGD","LU2592432038.USD","BK4583","LU0306806265.USD","LU2430703251.USD","LU1883839398.USD","LU2505996681.GBP","LU0203345920.USD","LU1280957306.USD","LU0792757196.USD","IE00B4R5TH58.HKD","LU1506573853.SGD","LU2430703095.HKD","LU1244550494.USD","LU1032955483.USD","LU1267930813.SGD","LU0795875086.SGD","LU1066051225.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2590544050","title":"AstraZeneca PLC ADR Falls Thursday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2590544050","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590544050?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:21","pubTimestamp":1765491660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.The AstraZeneca PLC ADR  shed 1.33% to $90.29 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 1.34% to 48,704.01 and the NASDAQ Composite Index  falling 0.25% to 23,593.86.AstraZeneca PLC ADR closed 3.96% short of its 52-week high of $94.02, which the company reached on November 26th.The ADR demonstrated a mixed performance when compared to some of its competitors Thursday, as Eli Lilly & Co.  rose 1.58% to $1,009.38, Biogen Inc.  fell 2.84% to $172.50, and Johnson & Johnson  rose 1.68% to $210.01.Trading volume  eclipsed its 50-day average volume of 5.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 11, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","LU1261432733.SGD","LU2468319806.SGD","LU2129689514.USD","IE00B19Z3B42.SGD","LU1506573853.SGD","LU0323591593.USD","LU1914381329.SGD","LU2746668974.SGD","IE00BKVL7J92.USD","IE00B19Z9Z06.USD","LU1323610961.USD","LU2471134796.USD","LU1061106388.HKD","LU0385154629.USD","LU1221951046.USD","LU0320765992.SGD","SGXZ57979304.SGD","LU0471298694.HKD","LU0985320562.USD","BK4533","LU0079474960.USD","AZN","LU0070217475.USD","LU0203201768.USD","LU0466842654.USD","LU1066051225.USD","LU1674673428.USD","IE00BKPKM429.USD","IE00B1XK9C88.USD","LU0456855351.SGD","LU1551013342.USD","LU1244550221.USD","LU2236285917.USD","LU2237443978.SGD","LU0096364046.USD","LU2361045086.USD","LU0234570918.USD","IE000M9KFDE8.USD","LU0889565916.HKD","LU2462157665.USD","IE00B7KXQ091.USD","LU1430594728.SGD","IE00BWXC8680.SGD","LU1974910355.USD","LU1732800096.USD","LU2552382058.USD","LU1366192091.USD","IE0004445239.USD","LU1814569148.SGD","LU0266013472.USD","LU2063271972.USD","IE00B2B36J28.USD","LU1066053197.SGD","BK4588","LU0198837287.USD","BK4139","LU2430703251.USD","LU2168564222.USD","LU1496350502.SGD","LU1064131342.USD","IE00BJJMRZ35.SGD","LU0417517546.SGD","IE0002141913.USD","IE0002270589.USD","LU1868837300.USD","IE00B4R5TH58.HKD","LU0943347566.SGD","LU0114720955.EUR","LU2237443549.SGD","SGXZ81514606.USD","LU0795875169.SGD","IE0005OL40V9.USD","IE00BJLML261.HKD","IE00BVYPNV92.GBP","BK4559","LU0097036916.USD","IE00BGHQF631.EUR","LU2129689431.USD","LU0289739699.SGD","LU2471134952.CNY","LU0109391861.USD","LU0316494557.USD","LU0823434583.USD","SG9999014880.SGD","LU1221951129.SGD","LU2089984988.USD","LU1066051811.HKD","LU1623119135.USD","IE00BJJMRX11.SGD","LU2552382132.HKD","LU0203345920.USD","LU2430703095.HKD","SG9999015945.SGD","LU2361044865.SGD","LU0106261372.USD","LU2237438978.USD","IE00BFSS7M15.SGD","LU1551013425.SGD","LU1732799900.SGD","LU2491049909.HKD","LU2168564495.EUR","IE00B894F039.SGD","LU2023250504.SGD","LU0708995401.HKD","BK4599","LU1868836591.USD","SG9999001176.SGD","LU1674673691.USD","SG9999018865.SGD","LU0820561909.HKD","IE00BFSS8Q28.SGD","SG9999015952.SGD","BK4504","LU0006306889.USD","LU0109394709.USD","LU0345770993.USD","LU1244550577.SGD","LU0238689110.USD","LU0094547139.USD","LU2211815571.USD","LU1804176565.USD","LU2237443895.HKD","SG9999001440.SGD","IE00BVYPNW00.USD","LU1829250122.USD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","LU2106854487.HKD","LU2471134879.HKD","LU1232071149.USD","SGXZ31699556.SGD","LU0432979614.USD","LU0786609619.USD","LU1720051108.HKD","LU2471134523.USD","BK4592","LU1162221912.USD","IE00BLSP4239.USD","IE00BKDWB100.SGD","LU0203347892.USD","LU1267930730.SGD","LU1291159041.SGD","LU2746668461.USD","LU2750360641.GBP","BK4532","LU0823416689.USD","IE00BBT3K403.USD","GB00BDT5M118.USD","LU1585245621.USD","LU2592432038.USD","SG9999002232.USD","SGXZ51526630.SGD","IE00B42XCP33.USD","LU0820561818.USD","LU2108987350.USD","LU2237443382.USD","LU0256863902.USD","IE00BJT1NW94.SGD","LU0353189763.USD","LU0354030438.USD","LU1069344957.HKD","SG9999014914.USD","BK4516","LU0061475181.USD","LU0672654240.SGD","LU0256863811.USD","BK4550","IE00B1BXHZ80.USD","LU2237443465.HKD","LU1917777945.USD","LU2456880835.USD","LU1935042991.SGD","LU0058720904.USD","SG9999015986.USD","LU2552382215.SGD","LU0320765646.SGD","LU1023059063.AUD","LU2168564065.EUR","IE00BK4W5M84.HKD","SG9999001176.USD","IE0034235303.USD","SG9999017495.SGD","BK4585","LU0354030511.USD","LU0353189680.USD","LU1868836757.USD","IE0004445015.USD","LU2087625088.SGD","IE00BFXG1179.USD","LU0122379950.USD","SG9999015978.USD","LU0882574139.USD","LU1066051498.USD","LU1093756168.USD","LU1868837136.USD","LU2505996509.AUD","LU1929549753.HKD","LU1983299246.USD","LU1267930813.SGD","IE00BDGV0183.EUR","IE00BJJMRY28.SGD","LU2264538146.SGD","LU2461242641.AUD","SGXZ99366536.SGD","LU0234572021.USD","LU1032466523.USD","LU1057294990.SGD","LU1718418525.SGD","LU0345769631.USD","IE00B7SZLL34.SGD","LU0795875086.SGD","LU1074936037.SGD","SG9999013999.USD","LU0345769128.USD","LU0882574055.USD","IE00B19Z9P08.USD","LU1720051017.SGD","LU2430703178.SGD","LU2168563687.JPY","LU0320765059.SGD","BK4534","IE0009355771.USD","LU0823434740.USD","LU1196500208.SGD","LU2237443622.USD","LU2265009873.SGD","LU2602419157.SGD","IE00BK4W5L77.USD","LU2361044949.HKD","IE00B775H168.HKD","IE00BN29S564.USD","IE00BLSP4452.SGD","LU0098860793.USD","LU2129689605.HKD","SG9999018857.SGD","LU0203202063.USD","IE00B3T34201.USD","LU1989771016.USD","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU2491050154.USD","LU1093756325.SGD","SG9999014906.USD","LU2133065610.SGD","LU1894683264.USD","BK4581","LU1035775433.USD","SG9999002224.SGD","LU0889566641.SGD","LU1712237335.SGD","SG9999014898.SGD","LU1244550494.USD","IE00B3PB1722.GBP","LU2347655156.SGD","LU0912757837.SGD","IE00B4JS1V06.HKD","LU0471298777.SGD","LU1280957306.USD","LU2417539215.USD","LU2357305700.SGD","BK4007","LU0792757196.USD","LU1032955483.USD","LU2505996681.GBP","LU1868836914.USD","LU0689472784.USD","LU1059921491.USD","LU1548497426.USD","LU1127390331.HKD","LU0640476718.USD","LU1778281490.HKD","LU0345770308.USD","LU2168564149.EUR","LU2491050071.SGD","LU2360106947.USD","LU2750360997.AUD","BK4568","LU2324357040.USD","LU1988902786.USD"],"gpt_icon":0},{"id":"2590725544","title":"Jazz Pharmaceuticals SVP Technical Operations Mary Elizabeth Henderson Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590725544","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590725544?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:20","pubTimestamp":1765491608,"startTime":"0","endTime":"0","summary":"Mary Elizabeth Henderson, Senior Vice President of Technical Operations at Jazz Pharmaceuticals plc, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL2SjJgs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Jazz Pharmaceuticals SVP Technical Operations Mary Elizabeth Henderson Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00BN0W2W23.USD","LU0823416689.USD","JAZZ","BK4007","LU0889565916.HKD","LU0320765992.SGD","BK4533","IE00BN0W2V16.EUR","BK4532","IE00BN0W2T93.GBP"],"gpt_icon":0},{"id":"2590544147","title":"Impact Biomedical Inc. Files Preliminary Information Statement Outlining Authorized Corporate Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2590544147","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590544147?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:12","pubTimestamp":1765491147,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc. shareholders have authorized key corporate actions, including a Reverse Stock Split and changes to Authorized Shares. These actions were approved on March 28, 2025. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL4jW1CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AEI","BK4563","IBO","BK4024"],"gpt_icon":0},{"id":"2590544343","title":"BUZZ-Contineum Therapeutics falls on planned $75 million share sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2590544343","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590544343?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:59","pubTimestamp":1765490360,"startTime":"0","endTime":"0","summary":"BUZZ-Contineum Therapeutics falls on planned $75 million share sale** Drug developer Contineum Therapeutics' CTNM.O shares fall 2.5% to $12.74 in extended trading** CTNM kicks off public offering of $75 million worth of shares** Goldman Sachs, Leerink Partners, Stifel, RBC Capital Markets and William Blair are joint book-running managers for proposed offering** Proceeds will be used to advance the development of its experimental drug, PIPE-791, and to fund research and development activities, among other purposes** CTNM has 29.2 million outstanding shares for $365.4 million market cap, per LSEG data** All seven brokerages covering the stock rate it \"buy\" or higher; median PT $22 — data compiled by LSEG** As of last close, CTNM down 10.8% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nL6N3XH172:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2750360641.GBP","IE00BSNM7G36.USD","BK4504","LU0061475181.USD","LU1791807156.HKD","LU1894683348.USD","LU1868837136.USD","SF","LU0345770993.USD","LU2471134879.HKD","IE0004091025.USD","LU2237443895.HKD","BK4533","LU0048573561.USD","BK4585","BK4127","BK4552","LU1894683264.USD","LU0096364046.USD","LU2237438978.USD","LU2471134952.CNY","IE0034235188.USD","LU2237443549.SGD","LU2237443465.HKD","LU0345770308.USD","BK4007","BK4588","LU0251131958.USD","LU1804176565.USD","LU2471134796.USD","LU1868836914.USD","BK4516","BK4207","LU1868837300.USD","LU0251142724.SGD","IE00BFXG1179.USD","LU1668664300.SGD","LU2750360997.AUD","IE0004086264.USD","IE0002270589.USD","IE00B19Z3581.USD","LU1868836757.USD","MNSH","LU2237443382.USD","CTNM","LU0106831901.USD","BK4550","LU1868836591.USD","LU2237443622.USD","LU2237443978.SGD"],"gpt_icon":0},{"id":"2590544395","title":"Zoetis Raises Quarterly Dividend by 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590544395","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590544395?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:57","pubTimestamp":1765490220,"startTime":"0","endTime":"0","summary":"Zoetis raised its quarterly dividend 6% to 53 cents from 50 cents.The new payout, equal to $2.12 per share a year, represents an 1.8% annual yield based on Thursday's closing price of $117.66.The animal health company said the dividend will be paid on March 3 to shareholders of record as of Jan. 20.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zoetis Raises Quarterly Dividend by 6%","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU1941712264.USD","LU2028103732.USD","LU0385154629.USD","IE00B19Z9505.USD","BK4534","LU0471298694.HKD","LU2089283258.USD","LU0079474960.USD","LU2089284900.SGD","LU2308191902.HKD","BK4585","LU0345774391.USD","LU0158827781.USD","LU1941712348.USD","LU1721429402.USD","BK4007","LU0345774631.USD","LU1721429741.USD","LU2271345857.HKD","LU0289739699.SGD","LU2111349929.HKD","LU0158827948.USD","LU2360106947.USD","LU0107464264.USD","LU2023251221.USD","ZTS","BK4588","LU0471298777.SGD"],"gpt_icon":0},{"id":"2590892544","title":"Zoetis Ups Quarterly Dividend to $0.53 per Share, Payable Mar. 3 to Holders of Record on Jan. 20","url":"https://stock-news.laohu8.com/highlight/detail?id=2590892544","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590892544?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:53","pubTimestamp":1765490038,"startTime":"0","endTime":"0","summary":"Zoetis Ups Quarterly Dividend to $0.53 per Share, Payable Mar. 3 to Holders of Record on Jan. 20","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2111349929.HKD","LU0158827948.USD","LU0107464264.USD","LU2308191902.HKD","BK4007","LU0058720904.USD","LU2023251221.USD","LU0471298694.HKD","LU2271345857.HKD","LU0345774391.USD","LU0289739699.SGD","LU1721429741.USD","LU2089283258.USD","LU0158827781.USD","ZTS","LU0345774631.USD","LU2028103732.USD","BK4534","BK4585","LU2360106947.USD","IE00B19Z9505.USD","LU0079474960.USD","LU2089284900.SGD","LU1721429402.USD","BK4588","LU0471298777.SGD","LU1941712264.USD","LU0385154629.USD","LU1941712348.USD"],"gpt_icon":0},{"id":"2590954172","title":"Contineum Therapeutics Inc - Phase 2 Trial for Pipe-791 Expected to Be Completed in June 2028 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2590954172","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590954172?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:45","pubTimestamp":1765489517,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XH0RO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTNM","BK4007"],"gpt_icon":0},{"id":"2590541914","title":"Merck & Co. Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2590541914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590541914?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:32","pubTimestamp":1765488720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck & Co. Inc.  rose 1.42% to $99.01 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.21% to 6,901.00 and the Dow Jones Industrial Average  rising 1.34% to 48,704.01.This was the stock's second consecutive day of gains.Merck & Co. Inc. closed 6.45% short of its 52-week high of $105.84, which the company reached on November 25th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 1.68% to $210.01, Pfizer Inc.  rose 0.08% to $25.80, and Eli Lilly & Co.  rose 1.58% to $1,009.38.Trading volume  remained 1.7 million below its 50-day average volume of 13.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 11, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published indepe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU2264538146.SGD","LU1232071149.USD","LU0265550359.USD","GB00BDT5M118.USD","SG9999015945.SGD","MRK","LU2552382132.HKD","IE00B3PB1722.GBP","BK4550","IE0034235303.USD","LU0130517989.USD","IE00B4R5TH58.HKD","IE00BKDWB100.SGD","LU0795875086.SGD","LU2237443895.HKD","IE00BN8TJ469.HKD","LU1914381329.SGD","LU0965509101.SGD","BK4592","LU0070217475.USD","LU1989771016.USD","LU2129689605.HKD","IE0004445015.USD","IE00B7SZLL34.SGD","SG9999002224.SGD","LU2357305700.SGD","SG9999015341.SGD","LU1506573853.SGD","LU0321505439.SGD","LU2746668974.SGD","SG9999013999.USD","IE00BKPKM429.USD","IE00BLSP4452.SGD","IE00BFSS8Q28.SGD","LU2505996681.GBP","SG9999018857.SGD","LU1868836591.USD","IE00BFTCPJ56.SGD","LU1551013425.SGD","LU2430703251.USD","LU0912757837.SGD","LU2491050071.SGD","SG9999015952.SGD","IE00B7KXQ091.USD","LU1244550494.USD","IE00BJLML261.HKD","IE00B19Z3B42.SGD","SG9999014898.SGD","LU1430594728.SGD","LU0353189763.USD","LU0466842654.USD","IE00BN29S564.USD","LU1061106388.HKD","LU1732800096.USD","LU1127390331.HKD","SG9999003800.SGD","LU0079474960.USD","IE0009355771.USD","LU1571399168.USD","LU0323591593.USD","LU1868836914.USD","LU0203201768.USD","LU2023250843.SGD","SGXZ51526630.SGD","LU1988902786.USD","LU2324357040.USD","LU1032466523.USD","LU1934455863.HKD","SG9999018865.SGD","LU2347655156.SGD","LU0122379950.USD","LU0320765992.SGD","IE00BK4W5L77.USD","LU0823434583.USD","LU1941712264.USD","LU1929549753.HKD","BK4599","LU0006306889.USD","LU0109391861.USD","BK4588","LU0306806265.USD","LU2462157665.USD","LU0320765646.SGD","IE00B1XK9C88.USD","LU0456855351.SGD","LU1037948541.HKD","LU1116320737.USD","LU2552382215.SGD","IE00BZ1G4Q59.USD","IE00B42XCP33.USD","LU2129689514.USD","LU1162221912.USD","LU0096364046.USD","LU0109394709.USD","BK4581","IE00B3T34201.USD","LU0289739699.SGD","LU0792757196.USD","LU1989772923.USD","LU2133065610.SGD","LU1585245621.USD","LU0795875169.SGD","LU1064131342.USD","SG9999001440.SGD","LU1069344957.HKD","LU0417517546.SGD","LU1674673691.USD","LU0823434740.USD","LU1023059063.AUD","LU2089984988.USD","LU0114720955.EUR","LU0477156953.USD","SG9999014914.USD","IE00B19Z3581.USD","IE00BJT1NW94.SGD","LU0321505868.SGD","LU0345769128.USD","LU0345770993.USD","LU1059921491.USD","LU0170899867.USD","LU0070302665.USD","LU1066053197.SGD","LU1894683264.USD","BK4559","LU2592432038.USD","IE00BLSP4239.USD","LU0965509283.SGD","LU1732799900.SGD","BK4007","LU0985481810.HKD","LU0203345920.USD","LU0316494557.USD","LU1280957306.USD","LU1548497426.USD","LU0061475181.USD","LU1116320901.HKD","LU0265550946.USD","LU0320765059.SGD","LU1093756325.SGD","LU2168564222.USD","SG9999015358.SGD","IE00BSNM7G36.USD","IE00BGHQF631.EUR","LU0471298694.HKD","LU0965509010.AUD","LU1623119135.USD","LU1221951129.SGD","LU0256863811.USD","LU2361045086.USD","LU0211331839.USD","SGXZ81514606.USD","IE0002141913.USD","LU2750360641.GBP","LU1066051811.HKD","BK4568","LU1983299246.USD","LU1718418525.SGD","IE00BJJMRX11.SGD","LU0868494617.USD","LU2106854487.HKD","LU2430703178.SGD","LU1323610961.USD","LU2552382058.USD","LU2456880835.USD","LU0882574055.USD","IE00BDGV0183.EUR","LU1720051017.SGD","LU0640476718.USD","LU1196500208.SGD","LU0106261372.USD","LU0823416689.USD","LU2360106947.USD","LU0786609619.USD","LU1093756168.USD","LU1201861249.SGD","LU0889566641.SGD","LU2360032135.SGD","LU1261432733.SGD","SG9999014559.SGD","LU1934455277.USD","IE00B775H168.HKD","IE00BKVL7J92.USD","LU1035773651.USD","LU1814569148.SGD","LU0225771236.USD","LU1778281490.HKD","LU0238689110.USD","LU1868837136.USD","IE00B4JS1V06.HKD","LU0094547139.USD","LU0234572021.USD","LU1699723380.USD","LU0689472784.USD","SG9999014567.USD","LU1069347547.HKD","SG9999002232.USD","LU0980610538.SGD","LU0256863902.USD","LU2471134796.USD","BK4585","LU1720051108.HKD","LU2087625088.SGD","LU2602419157.SGD","LU1868837300.USD","LU0708995401.HKD","LU2168564149.EUR","LU1941712348.USD","IE00BVYPNW00.USD","SGXZ57979304.SGD","IE00BWXC8680.SGD","LU2430703095.HKD","LU0225284248.USD","LU0648001328.SGD","SG9999001176.USD","LU2108987350.USD","LU1057294990.SGD","LU0820561909.HKD","LU0203347892.USD","LU0471298777.SGD","LU2168563687.JPY","LU1267930730.SGD","LU0130102774.USD","LU1074936037.SGD","IE00B1BXHZ80.USD","LU1883839398.USD","LU0354030511.USD","LU0345770308.USD","SG9999015986.USD","LU1035775433.USD","LU1917777945.USD","BK4532","LU1244550221.USD","LU1989772840.SGD","LU2236285917.USD","SGXZ99366536.SGD","LU0098860793.USD","LU1244550577.SGD","BK4516","LU2417539215.USD","LU0385154629.USD","SG9999014575.USD","LU2237443622.USD","IE00BFSS7M15.SGD","LU0320765489.SGD","LU2505996509.AUD","LU0058720904.USD","IE00BJJMRY28.SGD","LU0266013472.USD","LU2237443549.SGD","SG9999014542.SGD","LU2129689431.USD","IE00BVYPNV92.GBP","LU1037948897.HKD","LU2023250504.SGD","LU0882574139.USD","LU2125154935.USD","LU0820561818.USD","LU1974910355.USD","LU2471134523.USD","LU1066051498.USD","LU2750360997.AUD","LU1066051225.USD","LU1291159041.SGD","LU0432979614.USD","SG9999015978.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","LU0943347566.SGD","SG9999011175.SGD","LU0097036916.USD","LU2063271972.USD","SG9999014906.USD","LU2237443978.SGD","LU2746668461.USD","LU1366192091.USD","LU2471134879.HKD","LU0889565916.HKD","IE000M9KFDE8.USD","LU0965508806.USD","LU0354030438.USD","LU2461242641.AUD","LU1868836757.USD","LU2491049909.HKD","LU1804176565.USD","LU2471134952.CNY","LU1221951046.USD","LU0353189680.USD","LU0203202063.USD","LU2168564495.EUR","IE0005OL40V9.USD","SG9999014880.SGD","LU2168564065.EUR","LU1934455194.USD","LU2491050154.USD","IE00BBT3K403.USD","LU2125154778.USD","LU1267930813.SGD","LU2468319806.SGD","LU1935042991.SGD","LU0345769631.USD","LU0985320562.USD","LU0672654240.SGD","LU1032955483.USD","LU1894683348.USD","LU2237438978.USD","IE00BFXG1179.USD","LU0198837287.USD","LU2237443465.HKD","IE00BK4W5M84.HKD","LU1551013342.USD","SG9999017495.SGD","BK4533","IE0004445239.USD","LU2211815571.USD","LU2112291526.USD","LU0234570918.USD","LU0306807586.USD","LU0208291251.USD","LU0861579265.USD","LU2361044865.SGD","LU1496350502.SGD","LU2237443382.USD","LU2361044949.HKD","BK4504","IE00B2B36J28.USD","LU1674673428.USD","SG9999001176.SGD","LU1712237335.SGD","LU2265009873.SGD","SGXZ31699556.SGD"],"gpt_icon":0},{"id":"2590557541","title":"Enliven Therapeutics Grants CEO Richard Fair Stock Option Inducement Package","url":"https://stock-news.laohu8.com/highlight/detail?id=2590557541","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590557541?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:22","pubTimestamp":1765488151,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics Inc. has granted an inducement stock option to Richard Fair, the company's new President and Chief Executive Officer. Fair received an option to purchase 875,000 shares of Enliven's common stock at an exercise price of $18.77 per share, which was the closing price on the grant date. The option will vest with 25% of the shares vesting on the first anniversary of the grant, and the remaining shares vesting in equal monthly installments over the following three years, contingent on continued service.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on December 11, 2025, and is solely responsible for the information","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL7SYxdz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"gpt_icon":0},{"id":"2590541328","title":"Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2590541328","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590541328?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:22","pubTimestamp":1765488140,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUAJLSL9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ELVN"],"gpt_icon":0},{"id":"2590541303","title":"BioAge Labs Chief Medical Officer Paul D. Rubin Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590541303","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590541303?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:21","pubTimestamp":1765488107,"startTime":"0","endTime":"0","summary":"Paul D. Rubin, Chief Medical Officer of Bioage Labs Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 11, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL6kyPs6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioAge Labs Chief Medical Officer Paul D. Rubin Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2590254909","title":"BRIEF-Zoetis Declares First Quarter 2026 Dividend Board Approves 6% Payment Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2590254909","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590254909?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:16","pubTimestamp":1765487817,"startTime":"0","endTime":"0","summary":"BRIEF-Zoetis Declares First Quarter 2026 Dividend Board Approves 6% Payment IncreaseDec 11 (Reuters) - Zoetis Inc ZTS.N:ZOETIS DECLARES FIRST QUARTER 2026 DIVIDEND; BOARD APPROVES 6% PAYMENT INCREASEZ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XH1BM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU0345774391.USD","ZTS","LU1941712264.USD","BK4588","BK4534","LU0107464264.USD","LU2360106947.USD","BK4007","LU1721429741.USD","LU2089283258.USD","LU2089284900.SGD","IE00B19Z9505.USD","LU0289739699.SGD","LU0058720904.USD","LU0471298694.HKD","LU0471298777.SGD","LU0345774631.USD","LU0385154629.USD","LU2271345857.HKD","LU1721429402.USD","LU1941712348.USD","BK4585","LU2308191902.HKD","LU2028103732.USD","LU0158827948.USD","LU2023251221.USD","LU2111349929.HKD","LU0158827781.USD"],"gpt_icon":0},{"id":"2590654970","title":"Zoetis Inc - Declares Dividend of $0.53 per Share for Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590654970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590654970?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:16","pubTimestamp":1765487780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XH1BM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2028103732.USD","LU0158827781.USD","LU2271345857.HKD","LU0079474960.USD","IE00B19Z9505.USD","BK4007","LU0289739699.SGD","LU0107464264.USD","LU0345774631.USD","BK4588","LU0158827948.USD","LU2023251221.USD","LU1721429402.USD","LU1721429741.USD","LU2308191902.HKD","LU2089284900.SGD","LU1941712348.USD","LU2089283258.USD","BK4585","LU2111349929.HKD","ZTS","LU0385154629.USD","LU1941712264.USD","LU0471298694.HKD","LU0471298777.SGD","LU2360106947.USD","LU0345774391.USD","BK4534","LU0058720904.USD"],"gpt_icon":0},{"id":"2590562541","title":"Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry","url":"https://stock-news.laohu8.com/highlight/detail?id=2590562541","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590562541?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:15","pubTimestamp":1765487700,"startTime":"0","endTime":"0","summary":"HUNTSVILLE, Dec.  11, 2025  (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc.(“Serina” or the \"Company\") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3204315/0/en/Serina-Therapeutics-Strengthens-Leadership-Team-with-Appointment-of-Dr-Joshua-Thomas-as-VP-Head-of-Chemistry.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","TISI","BK4539","BK4231","BK4120","BK4080","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2590549270","title":"Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2590549270","media":"Reuters","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590549270?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:12","pubTimestamp":1765487560,"startTime":"0","endTime":"0","summary":"Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisitionOverviewBiotechnology firm's fiscal Q1 revenue rose yr/yrNet loss increased due to Cyclo acquisition expensesR&D expenses ro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nL1N3XH10Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4205","BK4233","BK4007","RFL"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction